Skip to main content
Premium Trial:

Request an Annual Quote

Bridge Capital Provides $7M Line of Credit for Fluidigm

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Bridge Capital Holdings and its subsidiary Bridge Bank National Association said after the close of the market on Thursday that they have provided Fluidigm with a $7 million line of credit.

The credit line was originally established in December 2010, when it was set at $4 million, according to a document filed with the US Securities and Exchange Commission in January.

The South San Francisco, Calif.-based company, which develops microfluidic systems for the life sciences and agricultural biotechnology industries, went public in February. Fluidigm CFO Vikram Jog said today that the financing will provide the company with greater flexibility to manage its working capital.